Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02647892 · ClinicalTrials.gov registry record · Phase 4
Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia
A Phase 4 study, sponsored by University of Nebraska.
- Terminated
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT02647892 is a Phase 4 study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 70 participants.
The verdict
NCT02647892, a Phase 4 study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the optimal amount of lidocaine buffering needed to decrease injection pain when administering local anesthesia.
Interventions
- DRUG sodium bicarbonate
- DRUG lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2016-01-08 |
| Est. Completion | 2021-11-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02647892
The ClinicalTrials.gov registry entry for NCT02647892 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sodium bicarbonate is the first listed.
NCT02647892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02647892 about?
NCT02647892 is a clinical study titled "Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia". The purpose of this study is to determine the optimal amount of lidocaine buffering needed to decrease injection pain when administering local anesthesia.
What is the current status of trial NCT02647892?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2016-01-08. Estimated completion is 2021-11-05.
What interventions are being tested in trial NCT02647892?
The interventions under investigation include: sodium bicarbonate (DRUG), lidocaine (DRUG).
Who is sponsoring clinical trial NCT02647892?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.